{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:46:25Z","timestamp":1773189985798,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570501"],"award-info":[{"award-number":["81570501"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770554"],"award-info":[{"award-number":["81770554"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772607"],"award-info":[{"award-number":["81772607"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472311"],"award-info":[{"award-number":["81472311"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12876-019-1049-2","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T12:03:55Z","timestamp":1564574635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The culprit of mesalamine intolerance: case series and literature review"],"prefix":"10.1186","volume":"19","author":[{"given":"Cheng","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runze","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangjing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaifang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8878-3131","authenticated-orcid":false,"given":"Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"1049_CR1","doi-asserted-by":"crossref","unstructured":"Wang Y, Parker CE, Feagan BG, MacDonald JK. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2016;5:CD000544.","DOI":"10.1002\/14651858.CD000544.pub4"},{"key":"1049_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/ajg.2011.67","volume":"106","author":"AC Ford","year":"2011","unstructured":"Ford AC, Achkar JP, Khan KJ, Kane SV, Talley NJ, Marshall JK, et al. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:601\u201316.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1049_CR3","first-page":"6","volume":"12","author":"L Blecher","year":"1995","unstructured":"Blecher L. Excipients\u2014the important components. Pharm Process. 1995;12(1):6\u20137.","journal-title":"Pharm Process"},{"key":"1049_CR4","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1136\/gut.44.6.886","volume":"44","author":"P Deltenre","year":"1999","unstructured":"Deltenre P, Berson A, Marcellin P, Degott C, Biour M, Pessayre D. Mesalazine (5-aminosalicylic acid) induced chronic hepatitis. Gut. 1999;44:886\u20138.","journal-title":"Gut."},{"key":"1049_CR5","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/j.1572-0241.1999.01245.x","volume":"94","author":"M Braun","year":"1999","unstructured":"Braun M, Fraser GM, Kunin M, Salamon F, Tur-Kaspa R. Mesalamine-induced granulomatous hepatitis. Am J Gastroenterol. 1999;94:1973\u20134.","journal-title":"Am J Gastroenterol"},{"key":"1049_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/00005176-199311000-00019","volume":"17","author":"AM Abdullah","year":"1993","unstructured":"Abdullah AM, Scott RB, Martin SR. Acute pancreatitis secondary to 5-aminosalicylic acid in a child with ulcerative colitis. J Pediatr Gastroenterol Nutr. 1993;17:441\u20134.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1049_CR7","first-page":"2302","volume":"92","author":"J Fernandez","year":"1997","unstructured":"Fernandez J, Sala M, Panes J, Feu F, Navarro S, Teres J. Acute pancreatitis after long-term 5-aminosalicylic acid therapy. Am J Gastroenterol. 1997;92:2302\u20133.","journal-title":"Am J Gastroenterol"},{"key":"1049_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2036.2000.00683.x","volume":"14","author":"G Corrigan","year":"2000","unstructured":"Corrigan G, Stevens PE. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease. Aliment Pharmacol Ther. 2000;14:1\u20136.","journal-title":"Aliment Pharmacol Ther"},{"key":"1049_CR9","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/oxfordjournals.ndt.a027787","volume":"12","author":"L Manenti","year":"1997","unstructured":"Manenti L, De Rosa A, Buzio C. Mesalazine-associated interstitial nephritis: twice in the same patient. Nephrol Dial Transplant. 1997;12:2031.","journal-title":"Nephrol Dial Transplant"},{"key":"1049_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/00004836-199701000-00007","volume":"24","author":"S Sviri","year":"1997","unstructured":"Sviri S, Gafanovich I, Kramer MR, Tsvang E, Ben-Chetrit E. Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature. J Clin Gastroenterol. 1997;24:34\u20136.","journal-title":"J Clin Gastroenterol"},{"key":"1049_CR11","first-page":"113","volume":"308","author":"AG Lim","year":"1994","unstructured":"Lim AG, Hine KR. Fever, vasculitic rash, arthritis, pericarditis, and pericardial effusion after mesalazine. BMJ. 1994;308:113.","journal-title":"BMJ."},{"key":"1049_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00005176-199710000-00015","volume":"25","author":"GC Kaiser","year":"1997","unstructured":"Kaiser GC, Milov DE, Erhart NA, Bailey DJ. Massive pericardial effusion in a child following the administration of mesalamine. J Pediatr Gastroenterol Nutr. 1997;25:435\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1049_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00004836-198812000-00012","volume":"10","author":"JM Fardy","year":"1988","unstructured":"Fardy JM, Lloyd DA, Reynolds RPE. Adverse effects with oral 5-aminosalicyclic acid. J Clin Gastroenterol. 1988;10:635\u20137.","journal-title":"J Clin Gastroenterol"},{"key":"1049_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2165\/00003495-198938040-00003","volume":"38","author":"RN Brogden","year":"1989","unstructured":"Brogden RN, Sorkin EM. Mesalamine. A review of its phamacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease. Drugs. 1989;38:500\u201323.","journal-title":"Drugs."},{"key":"1049_CR15","first-page":"579","volume":"231","author":"JM Smith","year":"1987","unstructured":"Smith JM. Allergic reactions to drug excipients. Practitioner. 1987;231:579\u201380 583.","journal-title":"Practitioner."},{"key":"1049_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/bmj.299.6700.649","volume":"299","author":"I Pollock","year":"1989","unstructured":"Pollock I, Young E, Stoneham M, Slater N, Wilkinson JD, Warner JO. Survey of colourings and preservatives in drugs. BMJ. 1989;299:649\u201351.","journal-title":"BMJ."},{"key":"1049_CR17","first-page":"1822","volume":"322","author":"RT Bell","year":"1990","unstructured":"Bell RT, Fishman S. Eosinophilia from food dye added to enteral feedings. N Engl J Med. 1990;322:1822.","journal-title":"N Engl J Med"},{"key":"1049_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/archneur.1988.00520320017006","volume":"45","author":"IS Login","year":"1988","unstructured":"Login IS. Unfavorable response to pink Tegretol tablets. Arch Neurol. 1988;45:831\u20132.","journal-title":"Arch Neurol"},{"key":"1049_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13256-015-0602-z","volume":"9","author":"S Barni","year":"2015","unstructured":"Barni S, Mori F, Pantano S, Novembre E. Adverse reaction to benzathine benzylpenicillin due to soy allergy: a case report. J Med Case Rep. 2015;9:134.","journal-title":"J Med Case Rep"},{"key":"1049_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1600-0536.2011.01881.x","volume":"64","author":"A Barbaud","year":"2011","unstructured":"Barbaud A, Waton J, Pinault AL, Bursztejn AC, Schmutz JL, Trechot P. Cutaneous adverse drug reactions caused by delayed sensitization to carboxymethylcellulose. Contact Dermatitis. 2011;64:294\u20137.","journal-title":"Contact Dermatitis"},{"key":"1049_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000070958","volume":"207","author":"PL Bigliardi","year":"2003","unstructured":"Bigliardi PL, Izakovic J, Weber JM, Bircher AJ. Anaphylaxis to the carbohydrate carboxymethylcellulose in parenteral corticosteroid preparations. Dermatology. 2003;207:100\u20133.","journal-title":"Dermatology."},{"issue":"5","key":"1049_CR22","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S1081-1206(10)61769-3","volume":"92","author":"AJ Bircher","year":"2004","unstructured":"Bircher AJ, Izakovic J. Oral tolerance of carboxymethylcellulose in patients with anaphylaxis to parenteral carboxymethylcellulose. Ann Allergy Asthma Immunol. 2004;92(5):580\u20131.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1049_CR23","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1034\/j.1398-9995.2003.00165.x","volume":"58","author":"Z Caliskaner","year":"2003","unstructured":"Caliskaner Z, Ozturk S, Karaayvaz M. Not all adverse drug reactions originate from active component: coloring agent-induced skin eruption in a patient treated with rifampicin. Allergy. 2003;58:1077\u20139.","journal-title":"Allergy."},{"key":"1049_CR24","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMc0904562","volume":"361","author":"A Duenas-Laita","year":"2009","unstructured":"Duenas-Laita A, Pineda F, Armentia A. Hypersensitivity to generic drugs with soybean oil. N Engl J Med. 2009;361:1317\u20138.","journal-title":"N Engl J Med"},{"key":"1049_CR25","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1600-0536.2009.01636.x","volume":"61","author":"S Field","year":"2009","unstructured":"Field S, Falvey E, Barry J, Bourke J. Type 1 hypersensitivity reaction to carboxymethylcellulose following intra-articular triamcinolone injection. Contact Dermatitis. 2009;61:302\u20133.","journal-title":"Contact Dermatitis"},{"key":"1049_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5694\/mja15.00084","volume":"203","author":"MJ Gooch","year":"2015","unstructured":"Gooch MJ, Okiwelu NL, Law T, McLean-Tooke AP, Joshi P. Warfarin or excipient allergy: a clinical dilemma resolved. Med J Aust. 2015;203:229.","journal-title":"Med J Aust"},{"key":"1049_CR27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/archneur.1991.00530200025008","volume":"48","author":"BS Koppel","year":"1991","unstructured":"Koppel BS, Harden CL, Daras M. Tegretol excipient-induced allergy. Arch Neurol. 1991;48:789.","journal-title":"Arch Neurol"},{"key":"1049_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1600-0536.2007.01092.x","volume":"57","author":"ME Laing","year":"2007","unstructured":"Laing ME, Fallis B, Murphy GM. Anaphylactic reaction to intralesional corticosteroid injection. Contact DermatitisS. 2007;57:132\u20133.","journal-title":"Contact DermatitisS"},{"key":"1049_CR29","first-page":"664","volume":"50","author":"J Millar","year":"2000","unstructured":"Millar J. Excipient E110: a cause for complaint? Br J Gen Pract. 2000;50:664.","journal-title":"Br J Gen Pract"},{"key":"1049_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/bja\/55.5.469","volume":"55","author":"DA Moneret-Vautrin","year":"1983","unstructured":"Moneret-Vautrin DA, Laxenaire MC, Viry-Babel F. Anaphylaxis caused by anti-cremophor EL IgG STS antibodies in a case of reaction to althesin. Brit J Anaesth. 1983;55:469\u201371.","journal-title":"Brit J Anaesth"},{"key":"1049_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/qjmed\/hcq175","volume":"104","author":"N Mumoli","year":"2011","unstructured":"Mumoli N, Cei M, Luschi R, Carmignani G, Camaiti A. Allergic reaction to Croscarmellose sodium used as excipient of a generic drug. QJM. 2011;104:709\u201310.","journal-title":"QJM."},{"key":"1049_CR32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1398-9995.2006.01287.x","volume":"62","author":"A Rogkakou","year":"2007","unstructured":"Rogkakou A, Guerra L, Scordamaglia A, Canonica GW, Passalacqua G. Severe skin reaction due to excipients of an oral iron treatment. Allergy. 2007;62:334\u20135.","journal-title":"Allergy."},{"key":"1049_CR33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(78)92815-5","volume":"2","author":"D Rubinger","year":"1978","unstructured":"Rubinger D, Friedlander M, Superstine E. Hypersensitivity to tablet additives in transplant recipients on prednisone. Lancet. 1978;2:689.","journal-title":"Lancet."},{"key":"1049_CR34","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1345\/aph.1K097","volume":"41","author":"RP Sims-McCallum","year":"2007","unstructured":"Sims-McCallum RP. Adverse reaction caused by excipients in mercaptopurine tablets. Ann Pharmacother. 2007;41:1548.","journal-title":"Ann Pharmacother"},{"key":"1049_CR35","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/S0140-6736(87)91147-0","volume":"2","author":"JP Hooff van","year":"1987","unstructured":"van Hooff JP, Bessems P, Beuman GH, Leunissen KM. Absence of allergic reaction to cyclosporin capsules in patient allergic to standard oral and intravenous solution of cyclosporin. Lancet. 1987;2:1456.","journal-title":"Lancet."}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-1049-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-019-1049-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-1049-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T22:39:18Z","timestamp":1568932758000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-019-1049-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1049"],"URL":"https:\/\/doi.org\/10.1186\/s12876-019-1049-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"20 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written and signed consent for publication has been obtained from the patients involved in the case series.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}